3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
4
Recurrence
2
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Hepatitis B
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Lamivudine
×
Clear all
NCT00555334
2009-04-01
LAM-RFA
Sun Yat-sen University
Phase 4
Unknown
200 enrolled